Latest Insider Transactions at Eliem Therapeutics, Inc. (ELYM)
This section provides a real-time view of insider transactions for Eliem Therapeutics, Inc. (ELYM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Eliem Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Eliem Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2024
|
Emily Pimblett CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,235
-9.83%
|
$2,470
$2.02 P/Share
|
|
Dec 18
2024
|
Emily Pimblett CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+28.47%
|
-
|
|
Sep 20
2024
|
Emily Pimblett CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,191
-6.81%
|
$9,528
$8.12 P/Share
|
|
Sep 18
2024
|
Emily Pimblett CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+36.35%
|
-
|
|
Jul 22
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
69,005
-43.9%
|
$552,040
$8.03 P/Share
|
|
Jul 19
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
60,201
-19.81%
|
$421,407
$7.17 P/Share
|
|
Jul 18
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
38,576
-19.38%
|
$231,456
$6.93 P/Share
|
|
Jul 17
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
3,207
-1.59%
|
$19,242
$6.91 P/Share
|
|
Jul 16
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
50,000
-19.82%
|
$350,000
$7.13 P/Share
|
|
Jul 15
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
42,377
-14.38%
|
$296,639
$7.01 P/Share
|
|
Jul 12
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
50,000
-14.51%
|
$350,000
$7.07 P/Share
|
|
Jul 11
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
50,000
-12.67%
|
$350,000
$7.11 P/Share
|
|
Jul 10
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
50,000
-11.24%
|
$300,000
$6.83 P/Share
|
|
Jul 09
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
5,931
-1.32%
|
$35,586
$6.66 P/Share
|
|
Jul 05
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
12,342
-2.67%
|
$86,394
$7.06 P/Share
|
|
Jul 03
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
50,000
-9.75%
|
$300,000
$6.76 P/Share
|
|
Jul 01
2024
|
Valerie Morisset EVP, R&D AND CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,649
+1.47%
|
-
|
|
Jun 27
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
13,008,546
+30.34%
|
$39,025,638
$3.84 P/Share
|
|
Jun 27
2024
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
5,259,872
+35.92%
|
-
|
|
Jun 27
2024
|
Stephen Basil Thomas |
BUY
Grant, award, or other acquisition
|
Direct |
103,907
+50.0%
|
-
|
|
Jun 20
2024
|
Emily Pimblett CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,245
-24.9%
|
$8,715
$7.21 P/Share
|
|
Jun 18
2024
|
Emily Pimblett CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
-
|
|
Apr 05
2024
|
Valerie Morisset EVP, R&D AND CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,847
+3.41%
|
-
|
|
Sep 20
2023
|
Valerie Morisset EVP, R&D AND CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,728
+2.09%
|
-
|
|
Mar 10
2023
|
Valerie Morisset EVP, R&D AND CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
316,410
+25.11%
|
-
|
|
Aug 12
2021
|
Ai Eti LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
800,000
+13.77%
|
$9,600,000
$12.5 P/Share
|
|
Aug 12
2021
|
Ai Eti LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,209,400
+50.0%
|
-
|
|
Aug 12
2021
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
6,867,517
+45.25%
|
-
|
|
Aug 12
2021
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
3,200,000
+25.42%
|
$38,400,000
$12.5 P/Share
|